Breaking ß Cell Tolerance After 100 Years of Life: Intratumoral Immunotherapy-Induced Diabetes Mellitus.

Quandt, Zoe; Coupe, Catherine; Anderson, Mark; Uihlein, Alexander; Young, Arabella

Quandt, Zoe; Coupe, Catherine; Anderson, Mark; Uihlein, Alexander; Young, Arabella.

Afiliação

Quandt Z; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, University of California San Francisco, San Francisco, California.
Coupe C; Diabetes Center, University of California San Francisco, San Francisco, California.
Anderson M; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, University of California San Francisco, San Francisco, California.
Uihlein A; Diabetes Center, University of California San Francisco, San Francisco, California.
Young A; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, University of California San Francisco, San Francisco, California.

J Endocr Soc ; 4(10): bvaa114, 2020 Oct 01.

Article em En | MEDLINE | ID: mdl-32964173

Palavras-chave

T-VEC; autoimmune diabetes; immune toxicity; immune-related adverse events; intratumoral immunotherapy; type 1 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article